# A Study to Assess Safety, Tolerability, and Pharmacokinetics of Ascending Concentrations of Topical Ocular BL1332 in Healthy Volunteers

> **NCT06978244** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Bausch & Lomb Incorporated** · enrollment: 24 (actual)

## Conditions studied

- Ocular Pain

## Interventions

- **DRUG:** BL1332 ophthalmic solution
- **DRUG:** BL1332 ophthalmic vehicle

## Key facts

- **NCT ID:** NCT06978244
- **Lead sponsor:** Bausch & Lomb Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-07-29
- **Primary completion:** 2026-11
- **Final completion:** 2026-11
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2026-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06978244

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06978244, "A Study to Assess Safety, Tolerability, and Pharmacokinetics of Ascending Concentrations of Topical Ocular BL1332 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06978244. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*